Showing 5571-5580 of 5621 results for "".
- Ivantis Announces Results of Comparative MIGS Clinical Trialhttps://modernod.com/news/ivantis-announces-results-of-comparative-migs-clinical-trial/2480238/Ivantis, developer of the Hydrus Microstent, announced the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS). Results from the study will be presented by David Chang, MD, clinical professor of Ophthalmology at the University of California, San Francisco, during
- Aerie Pharmaceuticals Announces Appointment of Scott Laranjo as Director, Marketing, Roclatanhttps://modernod.com/news/aerie-pharmaceuticals-announces-appointment-of-scott-laranjo-as-director-marketing-roclatan/2480254/Aerie Pharmaceuticals announced the appointment of Scott Laranjo as Director, Marketing, Roclatan, reporting to Deanne Melloy, Aerie’s Vice President of Marketing. Mr. Laranjo will direct future marketing activities associated with Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005
- Alcon Introduces Systane Complete Solution for Dry Eyehttps://modernod.com/news/alcon-introduces-systane-complete-solution-for-dry-eye/2480262/Alcon has introduced Systane Complete, a new formula designed to provide soothing relief for every major type of dry eye. The new product joins the Systane family of dry eye drops as a first-line treatment option for people who suffer from evaporative dry eye, aqueous tear deficient dry eye, or m
- SIFI Announces Approval of Mini Well Ready IOL in Singaporehttps://modernod.com/news/sifi-announces-approval-of-mini-well-ready-iol-in-singapore/2480263/Italian ophthalmic company SIFI has announced the approval of the Mini Well Ready IOL by Singapore’s Health Science’s Authority. Mini Well Ready is an innovative, aspherical, EDOF, progressive IOL designed for the surgical correction of presbyopia. “It is today increasingly rec
- Dallas Lighthouse for the Blind to Merge With Envisionhttps://modernod.com/news/dallas-lighthouse-for-the-blind-to-merge-with-envision/2480267/Envision announced that it has acquired the Dallas Lighthouse for the Blind. Operations will continue as normal in Dallas, and the Dallas Lighthouse for the Blind name will be retained. Financial terms of the deal were not disclosed. The merger will have positive benefits both in Te
- Zepto Receives Award for Best Capsulotomy Technology 2017https://modernod.com/news/zepto-receives-award-for-best-capsulotomy-technology-2017/2480270/Mynosys Cellular Devices has announced that its flagship automated capsulotomy device, »Zepto, has been selected as the best capsulotomy technology by Cataract and Refrac
- Global Dry Eye Treatment Revenues to Grow to $4.9 Billion by 2022https://modernod.com/news/global-dry-eye-treatment-revenues-to-grow-to-49-billion-by-2022/2480272/Market Scope expects the global dry eye treatments market to grow at a healthy pace through 2022, as 2017 revenues of $3.7 billion climb to $4.9 billion. Revenues will climb most sharply in emerging markets and other developing nations where we forecast double-digit compounded annual growth rates
- Christina Y. Weng, MD, MBA, FASRShttps://modernod.com/profiles/christina-y-weng-md-mba-fasrs/LkEPMo/Christina Y. Weng, MD, MBA is Professor of Ophthalmology and the Vitreoretinal Diseases & Surgery Fellowship Program Director at the Baylor College of Medicine in Houston, Texas. She has a faculty appointment at the Level 1 trauma center, Ben Taub General Hospital. Dr. Weng was a prior recipient of…
- Christina Y. Weng, MD, MBA, FASRShttps://modernod.com/profiles/christina-y-weng-md-mba-fasrs/jlDYp6/
- John De Francescohttps://modernod.com/profiles/john-de-francesco/j1eQnA/